SOUTH EASTON, Mass. – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a pacesetter within the growth and sale of broadly enabling, pressure-based devices, consumables, and platform expertise options to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and meals & beverage industries, right now introduced the receipt of an order for the 12th and closing system scheduled to be constructed within the Company’s preliminary manufacturing run of its revolutionary BaroShear

Ok45 processing system. Based on the Company’s proprietary Ultra Shear Technology™️ (UST™️) platform, the BaroShear Ok45 is a novel and highly effective nanoemulsification system designed to resolve one of essentially the most important issues going through the worldwide hemp-derived cannabinoid business right now: methods to make hemp-derived cannabinoid oil successfully soluble in water, to optimize absorption and bioavailability when consumed or utilized. The cannabidiol market is projected to exceed $20B by 2024 (Forbes, May 2019).

Hemp-derived cannabinoids are extracted from the hemp plant in an oil. As with any oil-based product, it’s tough for the water-based biology of our human our bodies to entry and take up the tiny hemp-derived cannabinoid molecules which can be hidden inside hemp oil drops. These drops stay comparatively massive after conventional aggressive emulsification strategies, which leads to poor and variable absorption ranges of hemp-derived cannabinoid molecules within the physique for the remedy of focused circumstances. Low or broadly various ranges of hemp-derived cannabinoid absorption and organic accessibility is a important difficulty which will considerably affect the bioavailability and effectiveness of the potential advantages of hemp-derived cannabinoid merchandise available on the market right now.


The Company beforehand introduced plans for its first manufacturing run of twelve (12) BaroShear Ok45 processing programs with estimated completion instances throughout the fourth quarter of 2020. Due to inefficiencies attributable to the COVID-19 pandemic, the Company now believes that each one 12 programs might be accomplished in time for cargo and set up to happen throughout the first quarter of 2021.

Mr. Kenneth F. Micciche, Director of PBI’s UST Program, stated: “The order for the last available BaroShear K45 system from our initial production run was received from an exciting young company out of Massachusetts called Canopy CBD Farms, LLC. The senior management of Canopy CBD Farms is comprised of very knowledgeable and experienced entrepreneurs and business leaders. They have already garnered the trust and loyalty of countless businesses in or entering in the commercial industrial hemp space. They use only the highest quality hemp biomass available and the latest processing technologies to meet or exceed industry standards. We are very pleased to have them as a customer.”

Mr. John Westlake, Founder and President of Canopy CBD Farms, LLC., commented: “Scientific data strongly supports the critical understanding that hemp-derived cannabinoid oil needs to be processed into an effectively water-soluble, long-term stable nanoemulsion to achieve the highest quality hemp-derived cannabinoid products possible. After an exhaustive review of available technologies, a thorough evaluation of UST-processed hemp-derived cannabinoid materials, and a detailed and encompassing site visit, we concluded the BaroShear K45 was unmatched in the universe of nanoemulsion processing platforms. As we are dedicated to using only the best equipment in our own manufacturing, and convinced that the BaroShear K45 will give us many competitive advantages in the marketplace, it was an easy decision for us to place this order for the 12th and last BaroShear K45 system in PBI’s initial manufacturing run.”

Mr. Richard T. Schumacher, President and CEO of PBI, commented: “We are extremely gratified and excited that the initial manufacturing run of our BaroShear K45 processing systems has sold out. We are also pleased that an impressive, up-and-coming company like Canopy CBD Farms was able to participate in and place an order for the final available unit in our first manufacturing run. We are confident that the BaroShear K45 will differentiate them in the marketplace with a substantial advantage over their competition.”

Mr. Schumacher continued: “Much progress has been made in the development of this very novel and innovative nanoemulsification processing system. We have finished the development of and run many processing cycles with the test bed. Our team is now beginning development of the BaroShear K45 alpha (first) unit. We expect to complete this unit by the end of September 2020 so it will be available for testing by the companies who placed the initial 12 orders. Upon their approval, we expect to ship and install all 12 BaroShear K45 systems during Q1 2021, at which point we will recognize approximately $2.4 million in revenue. This is a very exciting milestone event for all shareholders in Pressure BioSciences.”

About Canopy CBD Farms, LLC.
Canopy CBD Farms is a state licensed Massachusetts hemp processor and manufacturing firm. Foreseeing the long run of authorities rules, we’re strategically aligning ourselves with established FDA registered laboratories and producers to deliver the best of requirements and high quality of hemp-derived CBD merchandise. Canopy CBD farms serves pharmaceutical and medical analysis firms, wishing to determine white label/co-branded manufacturing partnerships with cGMP, GLP producers. Our partnerships will enhance wholesale and retail distribution channels, with a able to label line of top quality, salable hemp-derived CBD merchandise, for a range of makes use of and industries.

About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a pacesetter within the growth and sale of modern, broadly enabling, pressure-based options for the worldwide life sciences and different industries. Our merchandise are based mostly on the distinctive properties of each fixed (i.e., static) and alternating (i.e., strain biking expertise, or PCT) hydrostatic strain. PCT is a patented enabling expertise platform that makes use of alternating cycles of hydrostatic strain between ambient and ultra-high ranges to regulate bio-molecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). Our major focus is within the growth of PCT-based merchandise for biomarker and goal discovery, drug design and growth, biotherapeutics characterization and high quality management, soil & plant biology, forensics, and counter-bioterror functions. Additionally, main new market alternatives have emerged within the use of our pressure-based applied sciences within the following areas: (1) the use of our just lately acquired, patented expertise from BaroFold, Inc. (the “BaroFold” expertise) to permit entry into the bio-pharma contract providers sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create secure nanoemulsions of in any other case immiscible fluids (e.g., oils and water) and to (ii) put together greater high quality, homogenized, prolonged shelf-life or room temperature secure low-acid liquid meals that can not be successfully preserved utilizing current non-thermal applied sciences.

Source link